Alpha Capital Management’s Edwards Lifesciences EW Stock Holding History

Alpha Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,948	Closed	-$1.5M	–	91
2018 Q2	$1.5M	Sell	30,948 -2,220	-7%	-$104K	0.61%	54
2018 Q1	$1.54M	Sell	33,168 -897	-3%	-$39K	0.66%	48
2017 Q4	$1.28M	Buy	34,065 +153	+0.5%	+$5.62K	0.6%	55
2017 Q3	$1.24M	Buy	+33,912	New	+$1.29M	0.59%	56
2017 Q2	–	Hold	0	–	–	–	45
2017 Q1	–	Sell	-32,313	Closed	-$1.01M	–	50
2016 Q4	$1.01M	Buy	+32,313	New	+$1.05M	0.69%	52
2016 Q3	–	Sell	-34,680	Closed	-$1.15M	–	88
2016 Q2	$1.15M	Buy	+34,680	New	+$1.19M	0.83%	53

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alpha Capital Management's EW Position: Q3 2018 in Review

Alpha Capital Management sold out of Edwards Lifesciences (EW) in Q3 2018, closing a stake of 30,948 shares — an estimated $1.5M sold.

Alpha Capital Management first reported a position in EW in Q2 2016 and held it in 6 quarters. The position peaked at $1.54M in Q1 2018. 853 funds tracked by Wall St. Rank hold EW as of Q3 2018.

Alpha Capital Management reported no remaining Edwards Lifesciences position as of Q3 2018 after selling out during the quarter.
Alpha Capital Management sold 30,948 Edwards Lifesciences shares in Q3 2018, an estimated $1.5M.
Alpha Capital Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 6 quarters.
Alpha Capital Management's Edwards Lifesciences position peaked at $1.54M in Q1 2018.
853 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2018.

Based on Alpha Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.